FOUNDERS

Our founders formed a close partnership for one simple reason: to cure as many patients with innovative gene therapeutics as possible. This is our guiding principal.

We work every day to bring as many customized 4DMT vectors into as many great products as possible, for as many diseases and patients as possible.

DAVID KIRN, MD

CEO
co-founder, Chairman

Read Bio

DAVID SCHAFFER, PhD

Chief Scientific Advisor
co-founder

Read Bio

THERESA JANKE

Chief Operating Officer
co-founder

Read Bio

MELISSA KOTTERMAN, PhD

Vice President,
Discovery & Engineering
(founding management team)

Read Bio